Equities

ReproCell Inc

ReproCell Inc

Actions
  • Price (EUR)0.595
  • Today's Change0.015 / 2.59%
  • Shares traded0.00
  • 1 Year change-55.26%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments6,5676,3794,642
Total Receivables, Net421446348
Total Inventory248234259
Prepaid expenses------
Other current assets, total163123130
Total current assets7,3997,1825,379
Property, plant & equipment, net20010198
Goodwill, net111416
Intangibles, net131.3913
Long term investments1,3821,0052,540
Note receivable - long term------
Other long term assets485249
Total assets9,0538,3568,095
LIABILITIES
Accounts payable170207293
Accrued expenses6.747.6512
Notes payable/short-term debt000
Current portion long-term debt/capital leases--080
Other current liabilities, total502535442
Total current liabilities678750827
Total long term debt000
Total debt0080
Deferred income tax54239.64
Minority interest----0
Other liabilities, total8.977.767.63
Total liabilities741781845
SHAREHOLDERS EQUITY
Common stock2,3222,0241,715
Additional paid-in capital6,3806,0826,313
Retained earnings (accumulated deficit)(543)(515)(745)
Treasury stock - common(0.92)(0.92)(0.92)
Unrealized gain (loss)1361918
Other equity, total18(33)(50)
Total equity8,3127,5757,251
Total liabilities & shareholders' equity9,0538,3568,095
Total common shares outstanding898582
Treasury shares - common primary issue0.070.030.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.